In our study, TSP-1 hypermethylation was more frequent than RASSF2 hypermethylation, and more frequent in less aggressive grade I-II tumors than in more advanced grades (III-IV) [37], which is evidence of the early presence of this alteration in brain tumors. This evidence concerns the gene RASSF2 and brain neoplasm.